Dr. Yoojin Kim Pak, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd # 310, Lisle, IL 60532 Phone: 630-789-4910 Fax: 630-432-6744 |
Dr. Suchitra Bhakta, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 430 Warrenville Rd, 310, Lisle, IL 60532 Phone: 630-789-4910 |
News Archive
Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.
Participants in the German mammography screening program (MSP) who have invasive breast cancer—including interval cancers—can on the whole undergo more sparing surgical treatment compared with non-participants.
Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.
Researchers in the Blue Bird Circle Developmental Neurogenetics Laboratory in the department of neurology at Baylor College of Medicine have discovered that zinc enters cells through specialized protein gates known as ZIP transporters, and removing these ZIP proteins from cells in the hippocampus significantly protects them from injury.
When Amy Sweat was 19 years old, while she was in the hospital recovering from surgery, she was diagnosed with Type 2 diabetes. Ms. Sweat was treated for her diabetes, first on oral drugs, then on increasingly larger doses of insulin, but the years went by and she never was able to achieve good blood sugar control.
› Verified 8 days ago